Understanding the risks of vaping in adolescents
MARVEL: A Multidisciplinary Assessment of Risks from Vaping during Early Life
This study is looking at how vaping impacts the health and growth of young people aged 12 to 20, focusing on their habits, potential addiction, and both physical and mental effects, while also finding the best ways to help prevent vaping among teens.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11077343 on NIH RePORTER |
What this research studies
This research investigates how vaping affects the health and development of adolescents aged 12 to 20. It aims to assess vaping behaviors, the emergence of dependence, and the physiological and psychological impacts of vaping during critical developmental stages. The study will also evaluate effective prevention messages to reduce vaping among youth, based on empirical evidence gathered throughout the research. By taking a multidisciplinary approach, the project seeks to fill significant gaps in understanding the risks associated with adolescent vaping.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who are currently vaping or are at risk of developing vaping habits.
Not a fit: Patients who are not within the age range of 12 to 20 or who do not engage in vaping behaviors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for adolescents by providing insights into the dangers of vaping and effective prevention strategies.
How similar studies have performed: Previous research has shown promising results in understanding the impacts of vaping on health, indicating that this approach could yield valuable insights.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Sutfin, Erin L — Wake Forest University Health Sciences
- Study coordinator: Sutfin, Erin L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.